TONIX PHARMACEUTICALS HOLDING CORP. — Revenue by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/12c73f19-28ff-4e60-a0f4-8aaf45e81c49/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $13.1M | 2025-01-01 – 2025-12-31 | evidence 0001999371-26-005730 |
| FY 2024 | $10.1M | 2024-01-01 – 2024-12-31 | evidence 0001999371-25-002786 |
| FY 2023 | $7.8M | 2023-01-01 – 2023-12-31 | evidence 0001999371-24-004297 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TONIX PHARMACEUTICALS HOLDING CORP. — all facts · Net Income · Operating Income